Atlas Trials

a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients

Clinical trial NCT06248996 · RECRUITING

Trial details

NCT number
NCT06248996
Sponsor
Lund University Hospital
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2024-03-04
Primary completion
2028-03-04
Enrollment
308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.